The Deen's ListTM
Our Goal: To outperform the S&P through up markets and down.
A service of Deen Capital Management, Inc. (www.deencapital.com)
Vol.6 #305 Friday, September 19, 2008 10:44AM EDT

Please read carefully our disclaimers at the end of this newsletter.

Market Stance: BULLISH (since September 18, 2008)

Contents

Performance
Sold Covidien, Ltd. (COV) +1.9%
Open Positions
Subscription Information
Privacy Policy
Disclaimers
Contact Us

Performance

Deen Capital S&P 500
Year-to-date as of September 18, 2008 -15.2% * -16.6%
12 months (Sep 18, 2007 to Sep 18, 2008) -12.2% * -19.0%

* An average of managed accounts, net after all commissions and fees.

Click here for more performance data.

Click here for information on managed accounts.

Sold Covidien, Ltd. (COV) +1.9%

Net sell price in managed accounts*$53.60
Date(s) boughtAug 5 2008
Net buy price in managed accounts*$52.60
Holding period6.4 weeks
Gain/loss in managed accounts*+1.9% (after commissions)

* Buy and sell prices shown are net after commissions and fees. This means that the gain/loss shown is also net after transaction expenses.

Today, Friday, September 19, 2008, I sold COV, first for client accounts, then for my personal accounts.

The stock is down this morning on bad news. The company is now warning doctors that its injectable drug Phosphocol may increase the risk of leukemia in certain situations. This is reason enough for me to sell.

-KD, Friday, September 19, 2008

Open Positions

Model Portfolio

Company Name Stock
Symbol
Buy
Date
NetBuy
Price*
Current
Price**
Weeks
Held
% of
Portfolio
Gain
(Loss)
S&P Depository Receipt SPY 09/18/08 $120.17 $123.85 0.1 40.6% +3.1%
Royal Gold Inc. RGLD 09/18/08 $37.77 $37.80 0.1 5.8% +0.1%
Estee Lauder Cos Inc. EL 08/18/08 $51.31 $51.22 4.6 5.1% -0.2%
Thoratec Corp. THOR 08/05/08 $23.18 $27.86 6.4 7.5% +20.2%
Varian Medical Systems VAR 07/24/08 $59.79 $60.21 8.1 6.4% +0.7%
Cash 34.5%  
Total 100%  

* Buy prices shown are net after commissions and fees.

** Current prices are at least 20 minutes old.

Subscription Information

Welcome to The Deen's ListTM, an e-mail stock newsletter from Deen Capital Management, Inc.

My intention is to inform you as quickly as is practical regarding my stock market moves. When I buy or sell a stock, first I take care of client accounts, then I buy/sell for my personal account(s), and then, third, I send out this newsletter.

Your feedback is welcome. Send e-mail to deenslist@deencapital.com. To subscribe or unsubscribe, include the word "subscribe" or "unsubscribe" in the Subject line.

This newsletter is free to managed account clients. For a limited time, it is also free to all interested parties.

Privacy Policy

Your personal information, including your e-mail address, will be held in strict confidence by Deen Capital Management, Inc. We will not share it with or sell it to others.

Disclaimers

All stocks discussed in The Deen's ListTM involve a high degree of risk. It should not be assumed that any stock discussed in The Deen's ListTM or purchased by Deen Capital Management, Inc. will be profitable.

Past performance is not necessarily indicative of future results.

The information contained herein has been compiled from sources deemed to be reliable; however, we are not responsible for its accuracy or completeness.

Contact Us

The Deen's List
PO Box 30925
Santa Barbara, CA 93130
(800) 353-4990
deenslist@deencapital.com

Copyright © 2008 Deen Capital Management, Inc.